Aromasin
Aromasin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 20.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
20.0%
1 of 5 finished
80.0%
4 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
Clinical Trials (5)
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5